Cartesian Therapeutics, Inc. - COM (RNAC)

Historical Portfolio Holders from Q2 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
472
Holdings value Q2 2024
$11.1K
Value change Q2 2024
-$32.6M
Grand Portfolio weight change Q2 2024
0%
Number of holders
2
Number of buys Q2 2024
1
Number of sells Q2 2024
-57
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 472 $11.1K -$32.6M $13.75 2
2024 Q1 50.2M $32.7M +$389K $0.65 59
2023 Q4 51.7M $35.6M +$270K $0.69 76
2023 Q3 51.4M $54.5M -$3.19M $1.06 81
2023 Q2 54.1M $60.6M +$8.98M $1.12 87
2023 Q1 44.7M $62.2M -$3.41M $1.39 89
2022 Q4 53.5M $60.5M -$4.49M $1.13 79
2022 Q3 60.5M $99.2M +$8.44M $1.64 89
2022 Q2 58M $76M -$6.28M $1.31 86
2022 Q1 55.8M $69.1M -$2.02M $1.23 95
2021 Q4 55.9M $182M +$469K $3.26 103
2021 Q3 51.9M $217M -$1.94M $4.16 101
2021 Q2 52.4M $219M -$8.49M $4.18 99
2021 Q1 54.2M $245M +$20.4M $4.52 95
2020 Q4 50.6M $153M -$14.4M $3.03 89
2020 Q3 55.7M $138M +$1.63M $2.48 74
2020 Q2 61.3M $174M +$17.6M $2.84 82
2020 Q1 56.5M $136M +$39.3M $2.41 59
2019 Q4 40.2M $95M +$51.6M $2.38 38
2019 Q3 18.5M $32.4M -$4.09M $1.75 36
2019 Q2 20.8M $37.3M -$3.01M $1.79 42
2019 Q1 22.2M $52.6M +$27.5M $2.37 53
2018 Q4 10.5M $28M -$9.37M $2.66 54
2018 Q3 11.4M $178M +$8.57M $15.55 66
2018 Q2 10.9M $144M +$10.9M $13.25 56
2018 Q1 10.3M $105M -$5.52M $10.19 58
2017 Q4 10.9M $107M -$21.8M $9.81 61
2017 Q3 12.2M $222M +$6.05M $18.25 53
2017 Q2 11.8M $235M +$80M $19.86 47
2017 Q1 8.63M $124M +$9.03M $14.32 44
2016 Q4 8.18M $140M +$4.98M $17.15 42
2016 Q3 7.45M $106M -$217K $14.25 29
2016 Q2 7.49M $104M +$104M $13.99 17